BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26295711)

  • 1. Risk of Developing Depressive Disorders following Hepatocellular Carcinoma: A Nationwide Population-Based Study.
    Chang CH; Chen SJ; Liu CY
    PLoS One; 2015; 10(8):e0135417. PubMed ID: 26295711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.
    Huang YC; Huang CF; Chang KC; Hung SF; Wang JH; Hung CH; Chen CH; Tseng PL; Kee KM; Yen YH; Tsai PS; Tsai CC; Lu SN
    J Gastroenterol Hepatol; 2011 Jan; 26(1):129-34. PubMed ID: 21175806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of hip fractures in patients with depressive disorders: A nationwide, population-based, retrospective, cohort study.
    Pan CC; Hu LY; Lu T; Tu MS; Shen CC; Chen ZJ
    PLoS One; 2018; 13(4):e0194961. PubMed ID: 29641581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin.
    Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC
    Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediation Analysis of Hepatitis B and C in Relation to Hepatocellular Carcinoma Risk.
    Huang YT; Yang HI; Liu J; Lee MH; Freeman JR; Chen CJ
    Epidemiology; 2016 Jan; 27(1):14-20. PubMed ID: 26443934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative peg-interferon plus ribavirin is associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma.
    Hsu YC; Ho HJ; Wu MS; Lin JT; Wu CY
    Hepatology; 2013 Jul; 58(1):150-7. PubMed ID: 23389758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion-acquired HCV infection.
    Zavaglia C; Silini E; Mangia A; Airoldi A; Piazzolla V; Vangeli M; Stigliano R; Foschi A; Mazzarelli C; Tinelli C
    Liver Int; 2014 Aug; 34(7):e308-16. PubMed ID: 24529078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia and chronic liver diseases on risk of hepatocellular carcinoma in Chinese patients with type 2 diabetes--National cohort of Taiwan Diabetes Study.
    Li CI; Chen HJ; Lai HC; Liu CS; Lin WY; Li TC; Lin CC
    Int J Cancer; 2015 Jun; 136(11):2668-79. PubMed ID: 25387451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential impact of risk factors for tumor recurrence in hepatitis B and hepatitis C virus-infected patients undergoing liver transplantation for hepatocellular carcinoma.
    Krasnodębski M; Grąt M; Masior Ł; Patkowski W; Krawczyk M
    Ann Transplant; 2015 Feb; 20():70-5. PubMed ID: 25639825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
    Han XJ; Su HY; Shao HB; Xu K
    World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan.
    Inoue M; Yoshimi I; Sobue T; Tsugane S;
    J Natl Cancer Inst; 2005 Feb; 97(4):293-300. PubMed ID: 15713964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of type 2 diabetes on the development of hepatocellular carcinoma in different viral hepatitis statuses.
    Wang CS; Yao WJ; Chang TT; Wang ST; Chou P
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2054-60. PubMed ID: 19549812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hepatocellular carcinoma in diabetic patients and risk reduction associated with anti-diabetic therapy: a population-based cohort study.
    Lai SW; Chen PC; Liao KF; Muo CH; Lin CC; Sung FC
    Am J Gastroenterol; 2012 Jan; 107(1):46-52. PubMed ID: 22085817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
    Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P
    J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study.
    Wu CY; Lin JT; Ho HJ; Su CW; Lee TY; Wang SY; Wu C; Wu JC
    Gastroenterology; 2014 Jul; 147(1):143-151.e5. PubMed ID: 24704525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
    J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.
    Lee YT; Hu LY; Shen CC; Huang MW; Tsai SJ; Yang AC; Hu CK; Perng CL; Huang YS; Hung JH
    PLoS One; 2015; 10(7):e0133283. PubMed ID: 26222511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.